Characterizing circulating rare cells in peripheral blood for detecting and monitoring multiple myeloma and precursor states
Year: 2025
Type: article
Language: en
Topic: Multiple Myeloma Research and Treatments
Authors and affiliations:
raw_author_name: Stephanie N. Shishido
raw_affiliation_strings: Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA
raw_author_name: Jeremy Mason
raw_affiliation_strings: Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA
Institute of Urology, Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
raw_author_name: Mohamed Kamal
raw_affiliation_strings: Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA
raw_author_name: Sonia Maryam Setayesh
raw_affiliation_strings: Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA
raw_author_name: Amishi U. Vora
raw_affiliation_strings: Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: David Berrios
raw_affiliation_strings: Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Luz Yurany Moreno Rueda
raw_affiliation_strings: Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Krina Patel
raw_affiliation_strings: Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Elisabet E. Manasanch
raw_affiliation_strings: Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Robert Z. Orlowski
raw_affiliation_strings: Department of Experimental Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Peter Kuhn
raw_affiliation_strings: Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu
Department of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu
Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of South-ern California, Los Angeles, CA, USA. PKuhn@usc.edu
Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu
Institute of Urology, Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu
Department of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA